内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Processa Pharmaceuticals, Inc.

PCSA · Nasdaq · CIK 0001533743 · Healthcare · Biotechnology

内部人信号

68.4 / 100

6 位买方 · 27 条买入交易行 · $135.4K 买入总额

为什么有这个信号？

买方广度较强
买入规模较低
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+35.0 / 35
买入规模+8.8 / 25
角色+13.0 / 20
近期性+1.6 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Ng George KChief Executive Officer
●●●●●○
Young DavidPres. Research & Development
●●●●●
SKIBSTED RUSSELLChief Financial Officer
●●●●●
Lin PatrickChief Business - Strategy Off
●●●●●
Guy WendyChief Administrative Officer
●●●●●
Bigora SianChief Development Officer
●●
● 买入▼ 卖出○ 其他

Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方6
买入集中度22%最大买方： SKIBSTED RUSSELL · $29.9K
聚集买入 · 15天6 insiders峰值活动： 2026-04-30–2026-05-15

Roles in the peak window: Chief Administrative Officer, Chief Business - Strategy Off, Chief Development Officer, Chief Executive Officer, Chief Financial Officer, Pres. Research & Development. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

68.4 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 68.6
  2. 68.5
  3. 68.5
  4. 68.4
  5. 68.4

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

35买入
0卖出
9其他 Form 4 交易行
44SEC 申报 · 365天
买入27 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他5 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-17.8%
3M
-26.2%
6M
-45.1%
12M
-87.3%

波动率与流动性

波动率
153.1%
Beta
—
平均每日成交额
USD 414,943

估值

市值
USD 4.2M
P/E
—

基本面

利润率
—
ROE
-243.2%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-07 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
4,140
上期报告
14,995
日均成交量
23,095
回补天数
≤ 1.0

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-07-01Ng George K买入 (P)Common Stock3,057USD 1.93USD 5,900SEC 申报 ↗
2026-06-30Young David买入 (P)Common Stock2,531USD 1.93USD 4,885SEC 申报 ↗
2026-06-30SKIBSTED RUSSELL买入 (P)Common Stock3,277USD 1.93USD 6,325SEC 申报 ↗
2026-06-30Lin Patrick买入 (P)Common Stock2,106USD 1.93USD 4,065SEC 申报 ↗
2026-06-30Guy Wendy买入 (P)Common Stock2,436USD 1.93USD 4,701SEC 申报 ↗
2026-06-15Young David买入 (P)Common Stock2,067USD 2.22USD 4,589SEC 申报 ↗
2026-06-15SKIBSTED RUSSELL买入 (P)Common Stock2,654USD 2.22USD 5,892SEC 申报 ↗
2026-06-15Ng George K买入 (P)Common Stock2,465USD 2.22USD 5,472SEC 申报 ↗
2026-06-15Lin Patrick买入 (P)Common Stock1,831USD 2.22USD 4,065SEC 申报 ↗
2026-06-15Guy Wendy买入 (P)Common Stock2,118USD 2.22USD 4,702SEC 申报 ↗
2026-05-29Young David买入 (P)Common Stock1,786USD 2.57USD 4,590SEC 申报 ↗
2026-05-29SKIBSTED RUSSELL买入 (P)Common Stock2,292USD 2.57USD 5,890SEC 申报 ↗
2026-05-29Ng George K买入 (P)Common Stock2,129USD 2.57USD 5,472SEC 申报 ↗
2026-05-29Lin Patrick买入 (P)Common Stock1,582USD 2.57USD 4,066SEC 申报 ↗
2026-05-29Guy Wendy买入 (P)Common Stock1,829USD 2.57USD 4,701SEC 申报 ↗

Form 4 申报证据

44 transaction lines in the latest 365-day window; 190 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-08Ng George K期权行权／转换 (M)Common Stock1,600USD —USD —SEC 申报 ↗
2026-07-01Ng George K买入 (P)Common Stock3,057USD 1.93USD 5,900SEC 申报 ↗
2026-06-30Young David买入 (P)Common Stock2,531USD 1.93USD 4,885SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-08Ng George K期权行权／转换 (M)Common Stock1,600USD —USD —SEC 申报 ↗
2026-07-01Ng George K买入 (P)Common Stock3,057USD 1.93USD 5,900SEC 申报 ↗
2026-06-30Young David买入 (P)Common Stock2,531USD 1.93USD 4,885SEC 申报 ↗
2026-06-30SKIBSTED RUSSELL买入 (P)Common Stock3,277USD 1.93USD 6,325SEC 申报 ↗
2026-06-30Lin Patrick买入 (P)Common Stock2,106USD 1.93USD 4,065SEC 申报 ↗
2026-06-30Guy Wendy买入 (P)Common Stock2,436USD 1.93USD 4,701SEC 申报 ↗
2026-06-26Yorke Justin W期权行权／转换 (M)Common Stock203USD —USD —SEC 申报 ↗
2026-06-26Pannu Geraldine期权行权／转换 (M)Common Stock203USD —USD —SEC 申报 ↗
2026-06-26Neal James R期权行权／转换 (M)Common Stock203USD —USD —SEC 申报 ↗
2026-06-26Baluch Khoso期权行权／转换 (M)Common Stock203USD —USD —SEC 申报 ↗
2026-06-15Young David买入 (P)Common Stock2,067USD 2.22USD 4,589SEC 申报 ↗
2026-06-15SKIBSTED RUSSELL买入 (P)Common Stock2,654USD 2.22USD 5,892SEC 申报 ↗
2026-06-15Ng George K买入 (P)Common Stock2,465USD 2.22USD 5,472SEC 申报 ↗
2026-06-15Lin Patrick买入 (P)Common Stock1,831USD 2.22USD 4,065SEC 申报 ↗
2026-06-15Guy Wendy买入 (P)Common Stock2,118USD 2.22USD 4,702SEC 申报 ↗
2026-05-29Young David买入 (P)Common Stock1,786USD 2.57USD 4,590SEC 申报 ↗
2026-05-29SKIBSTED RUSSELL买入 (P)Common Stock2,292USD 2.57USD 5,890SEC 申报 ↗
2026-05-29Ng George K买入 (P)Common Stock2,129USD 2.57USD 5,472SEC 申报 ↗
2026-05-29Lin Patrick买入 (P)Common Stock1,582USD 2.57USD 4,066SEC 申报 ↗
2026-05-29Guy Wendy买入 (P)Common Stock1,829USD 2.57USD 4,701SEC 申报 ↗
2026-05-15Young David买入 (P)Common Stock1,545USD 2.97USD 4,589SEC 申报 ↗
2026-05-15SKIBSTED RUSSELL买入 (P)Common Stock1,984USD 2.97USD 5,892SEC 申报 ↗
2026-05-15Ng George K买入 (P)Common Stock1,843USD 2.97USD 5,474SEC 申报 ↗
2026-05-15Lin Patrick买入 (P)Common Stock1,369USD 2.97USD 4,066SEC 申报 ↗
2026-05-15Guy Wendy买入 (P)Common Stock1,583USD 2.97USD 4,702SEC 申报 ↗
2026-04-30Bigora Sian买入 (P)Common Stock1,971USD 2.71USD 5,341SEC 申报 ↗
2026-04-30Young David买入 (P)Common Stock1,706USD 2.69USD 4,589SEC 申报 ↗
2026-04-30SKIBSTED RUSSELL买入 (P)Common Stock2,190USD 2.69USD 5,891SEC 申报 ↗
2026-04-30Ng George K买入 (P)Common Stock2,034USD 2.69USD 5,471SEC 申报 ↗
2026-04-30Lin Patrick买入 (P)Common Stock1,511USD 2.69USD 4,065SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码PCSA
CIK0001533743
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史190 transaction lines from 2020-10-01 to 2026-08-08
66 P purchase lines · 17 S sale lines · 107 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.